JP2018532689A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532689A5
JP2018532689A5 JP2018502118A JP2018502118A JP2018532689A5 JP 2018532689 A5 JP2018532689 A5 JP 2018532689A5 JP 2018502118 A JP2018502118 A JP 2018502118A JP 2018502118 A JP2018502118 A JP 2018502118A JP 2018532689 A5 JP2018532689 A5 JP 2018532689A5
Authority
JP
Japan
Prior art keywords
functional fragment
radiolabeled
seq
composition according
vhh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018502118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532689A (ja
JP6917357B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/066934 external-priority patent/WO2017013026A1/en
Publication of JP2018532689A publication Critical patent/JP2018532689A/ja
Publication of JP2018532689A5 publication Critical patent/JP2018532689A5/ja
Application granted granted Critical
Publication of JP6917357B2 publication Critical patent/JP6917357B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018502118A 2015-07-17 2016-07-15 癌治療に使用する放射標識抗体断片 Active JP6917357B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562193700P 2015-07-17 2015-07-17
US62/193,700 2015-07-17
EP16153372 2016-01-29
EP16153372.4 2016-01-29
PCT/EP2016/066934 WO2017013026A1 (en) 2015-07-17 2016-07-15 Radiolabelled antibody fragments for use in treating cancer

Publications (3)

Publication Number Publication Date
JP2018532689A JP2018532689A (ja) 2018-11-08
JP2018532689A5 true JP2018532689A5 (enExample) 2019-05-16
JP6917357B2 JP6917357B2 (ja) 2021-08-11

Family

ID=57833837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018502118A Active JP6917357B2 (ja) 2015-07-17 2016-07-15 癌治療に使用する放射標識抗体断片

Country Status (9)

Country Link
US (2) US11298433B2 (enExample)
EP (1) EP3325020B1 (enExample)
JP (1) JP6917357B2 (enExample)
KR (2) KR20250174696A (enExample)
CN (1) CN108025093B (enExample)
AU (1) AU2016294858B2 (enExample)
CA (1) CA2991398A1 (enExample)
MX (1) MX390949B (enExample)
WO (1) WO2017013026A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7097636B2 (ja) * 2017-06-20 2022-07-08 ナノマブ テクノロジー リミテッド 抗Ｈｅｒ２ナノボディ及びそのコード序列と用途
EP3967674A1 (en) * 2020-09-11 2022-03-16 Precirix N.V. Reactions of radioactive compounds facilitated by a solid phase
CN112561871B (zh) * 2020-12-08 2021-09-03 中国医学科学院北京协和医院 一种基于平扫ct图像的主动脉夹层分割方法和装置
MX2023009761A (es) * 2021-02-22 2023-11-14 Abdera Therapeutics Inc Inmunoconjugados para terapia dirigida con radioisotopos.
CA3256757A1 (en) * 2022-05-23 2023-11-30 Cereius, Inc. HER2 LIAISON AGENTS AND THEIR USES
IL319125A (en) 2022-08-22 2025-04-01 Abdera Therapeutics Inc DLL3 binding molecules and their uses
CN116719074A (zh) * 2023-05-29 2023-09-08 中国核电工程有限公司 一种两栖生物辐射剂量率的获取方法及装置
WO2025034806A1 (en) 2023-08-08 2025-02-13 Wisconsin Alumni Research Foundation Single-domain antibodies and variants thereof against fibroblast activation protein
WO2025195495A1 (zh) * 2024-03-21 2025-09-25 启德医药科技（苏州）有限公司 一种放射性核素偶联物及其制备方法和用途
WO2026008881A1 (en) 2024-07-05 2026-01-08 Synaffix B.V. Extracellular vesicles comprising biomolecule-conjugates
US20260062453A1 (en) 2024-07-30 2026-03-05 Wisconsin Alumni Research Foundation Degradation targeting agents and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498427B1 (en) 1992-08-21 2009-12-16 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
DK0698097T3 (da) 1993-04-29 2001-10-08 Unilever Nv Produktion af antistoffer eller (funktionaliserede) fragmenter deraf afledt af Camelidae-immunoglobuliner med tung kæde
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
AU707159B2 (en) 1994-09-16 1999-07-01 Cancer Research Fund Of Contra Costa Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
AU740043B2 (en) 1996-06-27 2001-10-25 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Recognition molecules interacting specifically with the active site or cleft of a target molecule
BR9907241A (pt) 1998-01-26 2000-10-17 Unilever Nv Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo
WO2000040968A1 (en) 1999-01-05 2000-07-13 Unilever Plc Binding of antibody fragments to solid supports
WO2000043507A1 (en) 1999-01-19 2000-07-27 Unilever Plc Method for producing antibody fragments
ID30380A (id) 1999-04-22 2001-11-29 Unilever Nv Penghambatan infeksi virus menggunakan protein pengikat antigen bervalensi tunggal
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
DK1233987T3 (da) 1999-11-29 2009-09-28 Bac Ip B V Immobiliserede enkelt-domæne antigenbindende molekyler
EP1242460B1 (en) 1999-11-29 2006-10-18 Unilever Plc Immobilisation of proteins using a polypeptide segment
EP1134231B1 (en) 2000-03-14 2009-04-15 Unilever N.V. Antibody heavy chain variable domains against human dietary lipases, and their uses
CA2380443C (en) 2000-05-26 2013-03-12 Ginette Dubuc Single-domain antigen-binding antibody fragments derived from llama antibodies
US20040053340A1 (en) 2000-12-13 2004-03-18 De Haard Johannes Joseph Protein arrays
EP1433793A4 (en) 2001-09-13 2006-01-25 Inst Antibodies Co Ltd METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
AU2002351896A1 (en) 2001-12-11 2003-06-23 Ablynx N.V. Method for displaying loops from immunoglobulin domains in different contexts
AU2002360068B2 (en) 2001-12-21 2009-09-03 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method for cloning of variable domain sequences
JP2005517674A (ja) 2002-01-03 2005-06-16 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー 腫瘍の処置に有用な新規免疫コンジュゲート
WO2004041862A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP1558647B1 (en) 2002-11-08 2015-06-10 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
RU2357974C2 (ru) 2003-01-10 2009-06-10 Аблинкс Н.В. Терапевтические полипептиды, их гомологи, их фрагменты и их применение для модуляции агрегации, опосредованной тромбоцитами
US20090304590A1 (en) 2007-05-29 2009-12-10 Wyeth Therapeutic compositions and methods
CN101970490A (zh) * 2007-11-27 2011-02-09 埃博灵克斯股份有限公司 针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽
EP2143735A1 (en) 2008-07-10 2010-01-13 Institut Pasteur Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
US20110200525A1 (en) 2008-10-09 2011-08-18 Patz Jr Edward F Vhh antibody fragments for use in the detection and treatment of cancer
WO2010096486A1 (en) * 2009-02-17 2010-08-26 Cornell Research Foundation, Inc. Methods and kits for diagnosis of cancer and prediction of therapeutic value
WO2011051327A2 (en) 2009-10-30 2011-05-05 Novartis Ag Small antibody-like single chain proteins
AU2013201422B2 (en) 2012-01-23 2015-04-09 Ablynx Nv Sequences directed against hepatocyte growth factor (HFG) and polypeptides comprising the same for the treatment of cancers and/or tumors
JP6499090B2 (ja) 2013-03-15 2019-04-10 ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ 心血管疾患において使用するための抗マクロファージマンノース受容体単一可変ドメイン
EP3008093A1 (en) * 2013-06-11 2016-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-her2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer
WO2015073746A2 (en) 2013-11-13 2015-05-21 Whitehead Institute For Biomedical Research 18f labeling of proteins using sortases
JP6289733B2 (ja) 2014-07-29 2018-03-07 フレイエ ユニヴェルシテイト ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｔｅｉｔ Ｂｒｕｓｓｅｌ 癌の予防及び／又は治療に用いるための放射標識抗体断片
EP3180037A1 (en) * 2014-07-29 2017-06-21 Vrije Universiteit Brussel Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response

Similar Documents

Publication Publication Date Title
JP2018532689A5 (enExample)
Tolmachev Imaging of HER-2 overexpression in tumors for guiding therapy
Zhang et al. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA
Tolmachev et al. Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy
Sugiura et al. Radiolabeling strategies for tumor-targeting proteinaceous drugs
US20250345466A1 (en) Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy
Engfeldt et al. Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence
Rinne et al. PET and SPECT imaging of the EGFR family (RTK class I) in oncology
JP2020512281A5 (enExample)
JP6917357B2 (ja) 癌治療に使用する放射標識抗体断片
Mitran et al. Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
Tolmachev et al. Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
Reddy et al. Immuno-positron emission tomography in cancer models
Lindegren et al. Binding affinity, specificity and comparative biodistribution of the parental murine monoclonal antibody MX35 (Anti-NaPi2b) and its humanized version Rebmab200
JP2016528299A5 (enExample)
Walther et al. Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT
JP7688941B2 (ja) Ｃｄ８結合ポリペプチドおよびその使用
Sarcan et al. Monoclonal antibodies and immuno-PET imaging: An overview
Wållberg et al. Design and evaluation of radiolabeled tracers for tumor imaging
Salsano et al. PET imaging using radiolabelled antibodies: future direction in tumor diagnosis and correlate applications
Wållberg et al. Evaluation of the radiocobalt-labeled [MMA-DOTA-Cys61]-ZHER2: 2395-Cys affibody molecule for targeting of HER2-expressing tumors
Niu et al. Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression
Kong et al. Managing Lymphoma with Non‐FDG Radiotracers: Current Clinical and Preclinical Applications
JP2009292815A (ja) 腫瘍診断に使用するための抗−Ｍｅｔモノクローナル抗体、そのフラグメントおよび誘導体、対応する組成物およびキット
Suman et al. Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F (ab') 2 and F (ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphoma